D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Bitwise Crypto Industry Innovators ETF
BITQ
$447M
| $786K | ﹤0.01% |
32,066
-4,532
| -12% | -$115K |
|
3802
Limoneira
LMNR
$272M
| $785K | ﹤0.01% |
59,786
-4,555
| -7% | -$58.7K |
|
3803
MSCI
MSCI
$41.7B
| $784K | ﹤0.01% |
+1,400
| New | +$817K |
|
3804
PUT
Sibanye-Stillwater
SBSW
$9.05B
| $784K | ﹤0.01% |
92,300
| – | – |
|
3805
CALL
Xerox
XRX
$436M
| $783K | ﹤0.01% |
250,000
| – | – |
|
3806
PUT
Unusual Machines
UMAC
$1.19B
| $781K | ﹤0.01% |
+35,000
| New | +$648K |
|
3807
Westrock Coffee
WEST
$757M
| $780K | ﹤0.01% |
96,160
+63,945
| +198% | +$459K |
|
3808
CALL
WD-40
WDFC
$2.79B
| $780K | ﹤0.01% |
+3,200
| New | +$685K |
|
|
WYFI
3809
CALL
WhiteFiber Inc
WYFI
$759M
| $777K | ﹤0.01% |
+20,000
| New | +$484K |
|
3810
CALL
Nektar Therapeutics
NKTR
$2.53B
| $775K | ﹤0.01% |
+11,100
| New | +$812K |
|
3811
IDEAYA Biosciences
IDYA
$3.85B
| $774K | ﹤0.01% |
+20,763
| New | +$636K |
|
3812
Mistras Group
MG
$609M
| $773K | ﹤0.01% |
44,226
-41,805
| -49% | -$744K |
|
3813
Life Time Group Holdings
LTH
$9.66B
| $772K | ﹤0.01% |
18,900
-308,118
| -94% | -$9.78M |
|
3814
ADC Therapeutics
ADCT
$174M
| $770K | ﹤0.01% |
719,320
+476,144
| +196% | +$1.39M |
|
|
OPTU
3815
Optimum Communications Inc
OPTU
$401M
| $769K | ﹤0.01% |
530,505
-8,042,664
| -94% | -$10M |
|
3816
Riskified
RSKD
$860M
| $767K | ﹤0.01% |
152,211
-126,088
| -45% | -$588K |
|
3817
PUT
Halozyme
HALO
$12.5B
| $767K | ﹤0.01% |
9,800
| – | – |
|
3818
PUT
Vishay Precision Group
VPG
$839M
| $765K | ﹤0.01% |
+5,100
| New | +$473K |
|
3819
GrowGeneration
GRWG
$97.2M
| $762K | ﹤0.01% |
514,602
+134,340
| +35% | +$190K |
|
|
GAP
3820
The Gap Inc
GAP
$7.88B
| $760K | ﹤0.01% |
40,705
-481,179
| -92% | -$11.1M |
|
3821
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.23B
| $760K | ﹤0.01% |
+5,642
| New | +$737K |
|
3822
PUT
Procore
PCOR
$8.81B
| $760K | ﹤0.01% |
18,700
-30,200
| -62% | -$1.49M |
|
3823
PUT
Pilgrim's Pride
PPC
$7.26B
| $759K | ﹤0.01% |
+27,000
| New | +$830K |
|
3824
Univest Financial
UVSP
$1.17B
| $758K | ﹤0.01% |
17,330
-1,423
| -8% | -$55.7K |
|
3825
Relmada Therapeutics
RLMD
$473M
| $758K | ﹤0.01% |
+109,474
| New | +$765K |
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.